Northern Trust’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.2M Sell
510,246
-25,960
-5% -$1.64M ﹤0.01% 1367
2025
Q1
$28.4M Sell
536,206
-9,108
-2% -$482K ﹤0.01% 1420
2024
Q4
$30.5M Buy
545,314
+46,848
+9% +$2.62M ﹤0.01% 1436
2024
Q3
$26.1M Sell
498,466
-982
-0.2% -$51.4K ﹤0.01% 1458
2024
Q2
$20.5M Sell
499,448
-3,407
-0.7% -$140K ﹤0.01% 1548
2024
Q1
$21.8M Buy
502,855
+1,761
+0.4% +$76.3K ﹤0.01% 1534
2023
Q4
$23M Sell
501,094
-2,928
-0.6% -$135K ﹤0.01% 1517
2023
Q3
$11.6M Buy
504,022
+9,820
+2% +$225K ﹤0.01% 1894
2023
Q2
$8.15M Buy
494,202
+352,065
+248% +$5.81M ﹤0.01% 2211
2023
Q1
$2.54M Buy
142,137
+4,036
+3% +$72K ﹤0.01% 2835
2022
Q4
$4.02M Buy
138,101
+23,992
+21% +$699K ﹤0.01% 2615
2022
Q3
$2.8M Buy
114,109
+2,860
+3% +$70.1K ﹤0.01% 2823
2022
Q2
$462K Sell
111,249
-305,638
-73% -$1.27M ﹤0.01% 3562
2022
Q1
$4.8M Sell
416,887
-12,184
-3% -$140K ﹤0.01% 2603
2021
Q4
$4.28M Buy
429,071
+8,637
+2% +$86.2K ﹤0.01% 2784
2021
Q3
$5.49M Sell
420,434
-20,252
-5% -$264K ﹤0.01% 2667
2021
Q2
$8.63M Buy
440,686
+5,726
+1% +$112K ﹤0.01% 2474
2021
Q1
$9.25M Buy
434,960
+16,038
+4% +$341K ﹤0.01% 2350
2020
Q4
$12.5M Sell
418,922
-13,898
-3% -$413K ﹤0.01% 2105
2020
Q3
$9.38M Sell
432,820
-26,903
-6% -$583K ﹤0.01% 2146
2020
Q2
$10.3M Buy
459,723
+73,375
+19% +$1.64M ﹤0.01% 2081
2020
Q1
$5.88M Buy
386,348
+22,952
+6% +$349K ﹤0.01% 2201
2019
Q4
$8.34M Buy
363,396
+70,310
+24% +$1.61M ﹤0.01% 2293
2019
Q3
$6.33M Buy
293,086
+78,588
+37% +$1.7M ﹤0.01% 2411
2019
Q2
$4.72M Sell
214,498
-2,568
-1% -$56.5K ﹤0.01% 2598
2019
Q1
$5.95M Buy
217,066
+6,190
+3% +$170K ﹤0.01% 2457
2018
Q4
$5.67M Sell
210,876
-918
-0.4% -$24.7K ﹤0.01% 2424
2018
Q3
$6.18M Buy
211,794
+67,575
+47% +$1.97M ﹤0.01% 2568
2018
Q2
$4.51M Buy
144,219
+53,671
+59% +$1.68M ﹤0.01% 2732
2018
Q1
$1.8M Buy
90,548
+12,367
+16% +$246K ﹤0.01% 3154
2017
Q4
$2.27M Buy
+78,181
New +$2.27M ﹤0.01% 3075